Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AZTA

Azenta (AZTA)

Azenta Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AZTA
DataHoraFonteTítuloCódigoCompanhia
13/02/202518:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AZTAAzenta Inc
10/02/202519:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AZTAAzenta Inc
05/02/202509:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZTAAzenta Inc
05/02/202509:00PR Newswire (US)Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024NASDAQ:AZTAAzenta Inc
04/02/202518:10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AZTAAzenta Inc
30/01/202518:05PR Newswire (US)Azenta Announces the Election of Dipal Doshi to its Board of DirectorsNASDAQ:AZTAAzenta Inc
27/01/202518:05PR Newswire (US)Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and WebcastNASDAQ:AZTAAzenta Inc
23/01/202518:05PR Newswire (US)UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research ExcellenceNASDAQ:AZTAAzenta Inc
17/12/202419:30Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AZTAAzenta Inc
17/12/202419:29Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AZTAAzenta Inc
17/12/202419:28Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AZTAAzenta Inc
06/12/202418:32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AZTAAzenta Inc
19/11/202419:56PR Newswire (US)Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600NASDAQ:AZTAAzenta Inc
14/11/202410:00PR Newswire (US)Azenta to Participate in Stephens Annual Investment ConferenceNASDAQ:AZTAAzenta Inc
12/11/202418:05PR Newswire (US)Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFONASDAQ:AZTAAzenta Inc
04/11/202418:05PR Newswire (US)Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and WebcastNASDAQ:AZTAAzenta Inc
04/11/202410:41Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AZTAAzenta Inc
04/11/202410:00PR Newswire (US)Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive ValueNASDAQ:AZTAAzenta Inc
30/10/202417:05PR Newswire (US)Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing TestNASDAQ:AZTAAzenta Inc
04/09/202409:00PR Newswire (US)AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEONASDAQ:AZTAAzenta Inc
12/08/202417:05PR Newswire (US)GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week EventNASDAQ:AZTAAzenta Inc
06/08/202417:05PR Newswire (US)Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024NASDAQ:AZTAAzenta Inc
05/08/202417:05PR Newswire (US)Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 ConferenceNASDAQ:AZTAAzenta Inc
01/08/202417:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AZTAAzenta Inc
24/07/202417:05PR Newswire (US)Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and WebcastNASDAQ:AZTAAzenta Inc
22/07/202417:05PR Newswire (US)FinnGen Selects Azenta to Propel Personalized Medicine for Population Health StudyNASDAQ:AZTAAzenta Inc
04/06/202417:05PR Newswire (US)Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical ResearchNASDAQ:AZTAAzenta Inc
30/05/202409:01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:AZTAAzenta Inc
23/05/202417:05PR Newswire (US)Azenta to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:AZTAAzenta Inc
13/05/202417:46PR Newswire (US)Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UKNASDAQ:AZTAAzenta Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AZTA